Posters
Magnifying surgery (MAGS) in ARMD cases: this is it
Poster Details
First Author: A.Borkenstein AUSTRIA
Co Author(s): E. Borkenstein
Abstract Details
Purpose:
To assess in a clinical evaluation the functional results of implanting a magnifying high add IOL in eyes with progressed ARMD and cataracts. To determine the value of the Lentis MAX LS-313 MF80 (Oculentis, Germany) in enhancing quality of life and the individual independence in daily routine. To evaluate if a training program can even enhance the autonomy and increase self-reliance in the first months (6-12) postoperatively. The findings of our study named �â��MAGS-This is it�â�� should change the mindset from: �â��They don�Â�´t care about us�â�� to �â��You are not alone!�â��
Setting:
Borkenstein & Borkenstein Praxis f�Ã�¼r Augenheilkunde und Optometrie, Privatklinik der Kreuzschwestern Graz, Austria.
Methods:
In this case series subjects with clinical significant cataract and progressed ARMD (stable in OCT > 3 months) with BCDVA of 1.3 - 0.5 logMAR were included. In all cases the aspheric, biconvex, sector shaped foldable one-piece IOL (Lentis MAX LS-313 MF80, Oculentis Germany) with an IOL add power of 8.0 D was implanted in the better eye.
Results:
The postoperative results were divided into objective measured (BCNVA, BCDVA, OCT) and subjective measured (questionnaire regarding quality of life, independence, autonomy in daily routine) with a points-based system score. The BCDVA improved in all cases immediately after surgery, UCNVA improved in all cases but required more time (training, neuroadaption). No halos or glare were reported. ARMD (OCT) was stable in the postoperative course of 12 months.
Conclusions:
Our 1 year results show a very high patient satisfaction. All subjects ranked their quality of life higher than before. We found out that continuing improvement of independence can be achieved with training in the first 6 months after surgery. Implanting a high add IOL is a promising alternative in low-vision patients with ARMD and cataracts and is head and shoulders above the common lens removal and standard IOL procedure!
Financial Disclosure:
NONE
